Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/124315
Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
American Trypanosomiasis or Chagas disease (CD) is a neglected disease that affects Latin American people worldwide. Two old antiparasitic drugs, benznidazole and nifurtimox, are currently used for specific CD treatment with limited efficacy in chronic infections and frequent side effects. New drugs are needed for patients with chronic CD as well as for immunosuppressed patients, for whom the risk of reactivation is life-threatening. We describe a case of chronic CD and systemic lupus erythematosus (SLE) that required immunosuppression to control the autoimmune process. It was found that benznidazole induced a reduction, but not an elimination, of circulating Trypanosoma cruzi levels, whereas subsequent treatment with posaconazole led to a successful resolution of the infection, despite the maintenance of immunosuppressive therapy.
Matèries
Matèries (anglès)
Citació
Citació
PINAZO, Maria-jesus, ESPINOSA GARRIGA, Gerard, GÁLLEGO CULLERÉ, M. (montserrat), LÓPEZ-CHEJADE, Paulo luis, URBINA, Julio a., GASCÓN I BRUSTENGA, Joaquim. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. _American Journal of Tropical Medicine and Hygiene_. 2010. Vol. 82, núm. 4, pàgs. 583-587. [consulta: 20 de gener de 2026]. ISSN: 0002-9637. [Disponible a: https://hdl.handle.net/2445/124315]